Generali, Daniele
 Distribuzione geografica
Continente #
NA - Nord America 243
EU - Europa 219
AS - Asia 123
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 601
Nazione #
US - Stati Uniti d'America 242
SE - Svezia 71
SG - Singapore 61
IT - Italia 55
IE - Irlanda 31
ID - Indonesia 19
CN - Cina 18
CI - Costa d'Avorio 13
RU - Federazione Russa 13
DE - Germania 12
IN - India 11
FR - Francia 9
GB - Regno Unito 7
FI - Finlandia 6
ES - Italia 4
KR - Corea 4
NL - Olanda 4
BE - Belgio 3
HK - Hong Kong 2
HU - Ungheria 2
PH - Filippine 2
TR - Turchia 2
A1 - Anonimo 1
AT - Austria 1
AZ - Azerbaigian 1
BR - Brasile 1
CA - Canada 1
CZ - Repubblica Ceca 1
EU - Europa 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
Totale 601
Città #
Chandler 79
Singapore 47
Dublin 31
Ashburn 19
Jakarta 19
Abidjan 13
Moscow 13
Boston 12
Milan 12
Princeton 12
New York 10
Pune 10
Rome 8
Munich 7
Boardman 5
Helsinki 5
Los Angeles 4
Montepulciano 4
Paris 4
Seoul 4
Amsterdam 3
Ann Arbor 3
Brussels 3
Majadahonda 3
Marseille 3
San Mateo 3
Ankara 2
Bremen 2
Brescia 2
Budapest 2
Busto Arsizio 2
Campi Bisenzio 2
Chiswick 2
Dongyang 2
Hong Kong 2
London 2
Naples 2
Nova Milanese 2
Seattle 2
Seveso 2
Shanghai 2
Amman 1
Andover 1
Augusta 1
Baku 1
Beijing 1
Brno 1
Clearwater 1
Clifton 1
Council Bluffs 1
Falkenstein 1
Fisciano 1
Frankfurt am Main 1
Kilburn 1
Kunming 1
Lappeenranta 1
Madrid 1
Milpitas 1
Mumbai 1
New Bedfont 1
Padova 1
Pasay 1
Quezon City 1
Redmond 1
Ripalta Cremasca 1
Rochester 1
Santa Clara 1
Shenyang 1
São Paulo 1
Tel Aviv 1
Tokyo 1
Toronto 1
Vienna 1
Wilmington 1
Woodbridge 1
Xi'an 1
Zhengzhou 1
Totale 402
Nome #
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 77
Patients’ Engagement in Early Detection of COVID-19 Symptoms: An Observational Study in the Very Early Peak of the Pandemic in Italy in 2020 47
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 41
Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis 38
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 37
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer 36
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis 35
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer 35
Hypoxia-related biological markers as predictors of epirubicin- based treatment responsiveness and resistance in locally advanced breast cancer 34
New omics information for clinical trial utility in the primary setting 33
Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study 28
Role of targeted agents in neuroendocrine tumours: results from a meta-analysis 28
Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy" 27
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer 26
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: a meta-regression of randomised prospective studies 25
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study 24
Seroconversion in patients with cancer and oncology healthcare workers infected by SARS-CoV-2 24
Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications 16
Endocrine‐based treatments in clinically‐relevant subgroups of hormone receptor‐positive/her2‐negative metastatic breast cancer: Systematic review and meta‐analysis 12
Totale 623
Categoria #
all - tutte 5.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 1 0 0 1 1 0
2021/202260 0 0 2 2 4 1 1 4 4 1 18 23
2022/2023218 19 33 14 18 26 26 18 20 28 2 3 11
2023/2024196 7 53 9 9 15 20 14 14 3 14 24 14
2024/2025146 13 10 55 3 47 18 0 0 0 0 0 0
Totale 623